United States · FDA National Drug Code directory

Oxybutynin Chloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 43063-851_2fc3d8ae-3605-f8df-e063-6294a90ab12f
Product NDC: 43063-851
Form: TABLET
Composition / generic term: Oxybutynin Chloride
Labeler: PD-Rx Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20171222
Source listing expiry: 20261231

Source-listed ingredients

OXYBUTYNIN CHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE, PLASTIC (43063-851-01) · 43063-851-01
60 TABLET in 1 BOTTLE, PLASTIC (43063-851-60) · 43063-851-60
90 TABLET in 1 BOTTLE, PLASTIC (43063-851-90) · 43063-851-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →